Marknaden stängd -
Andra börsplatser
|
5-dagars förändring | Förändring 1 jan. | ||
753,00 DKK | +0,60 % |
|
+3,36 % | +5,24 % |
29.01. | SEB sänker Zealand Pharma till behåll (köp), riktkurs 800 danska kronor - BN | FW |
24.01. | Novo Nordisk stiger på positiva resultat för amycretin - viktminskning på 22 procent (uppdatering) | FW |
Skatteperiod: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
TILLGÅNGAR | ||||||||||
Cash And Equivalents | 1,08 md | 960 mn | 1,13 md | 1,07 md | 449 mn | |||||
Short Term Investments | 299 mn | 297 mn | - | - | - | |||||
Trading Asset Securities, Total | - | - | 299 mn | 109 mn | 1,18 md | |||||
Total Cash And Short Term Investments | 1,38 md | 1,26 md | 1,43 md | 1,18 md | 1,63 md | |||||
Accounts Receivable, Total | 751 tn | 46,48 mn | 73,02 mn | 116 mn | 122 mn | |||||
Other Receivables | 15,04 mn | 15,44 mn | 37,36 mn | 21,6 mn | 16,44 mn | |||||
Total Receivables | 15,79 mn | 61,93 mn | 110 mn | 137 mn | 139 mn | |||||
Inventory | - | 65,04 mn | 118 mn | 1,29 mn | 7,94 mn | |||||
Prepaid Expenses | 30,76 mn | 35,16 mn | 64,63 mn | - | - | |||||
Restricted Cash | - | - | - | - | - | |||||
Total Current Assets | 1,43 md | 1,42 md | 1,72 md | 1,32 md | 1,78 md | |||||
Gross Property Plant And Equipment | 192 mn | 138 mn | 290 mn | 237 mn | 220 mn | |||||
Accumulated Depreciation | −66,54 mn | −53,26 mn | −68,89 mn | −71,36 mn | −70,43 mn | |||||
Net Property Plant And Equipment | 125 mn | 213 mn | 221 mn | 165 mn | 150 mn | |||||
Long-term Investments | 35,63 mn | 32,33 mn | 26,91 mn | 37,84 mn | 21,38 mn | |||||
Other Intangibles, Total | 2,48 mn | 57,48 mn | 53,79 mn | - | 12,26 mn | |||||
Accounts Receivable Long-Term | - | - | - | 18,1 mn | 15,79 mn | |||||
Deferred Tax Assets Long-Term | - | 8,37 mn | 13,52 mn | 2,02 mn | 925 tn | |||||
Other Long-Term Assets, Total | 9,01 mn | 31,04 mn | 30,36 mn | - | - | |||||
Total Assets | 1,6 md | 1,76 md | 2,07 md | 1,54 md | 1,98 md | |||||
Skulder | ||||||||||
Accounts Payable, Total | 57,53 mn | 70,38 mn | 64,56 mn | 181 mn | 91,61 mn | |||||
Accrued Expenses, Total | 43,1 mn | 36,43 mn | 28,7 mn | - | 85,2 mn | |||||
Current Portion of Long-Term Debt | - | - | - | - | - | |||||
Current Portion of Leases | 7,69 mn | 14,07 mn | 14,9 mn | 14,73 mn | 16,66 mn | |||||
Current Income Taxes Payable | 614 tn | 30,39 mn | - | - | - | |||||
Unearned Revenue Current, Total | 56,25 mn | 53,18 mn | 53,03 mn | - | - | |||||
Other Current Liabilities | 29,95 mn | 151 mn | 173 mn | - | 91,12 mn | |||||
Total Current Liabilities | 195 mn | 355 mn | 334 mn | 195 mn | 285 mn | |||||
Long-Term Debt | - | - | 648 mn | 401 mn | - | |||||
Long-Term Leases | 78,07 mn | 116 mn | 125 mn | 108 mn | 103 mn | |||||
Unearned Revenue Non Current | 83,64 mn | 44,59 mn | 14,55 mn | - | - | |||||
Other Non Current Liabilities | - | 16,74 mn | 18,43 mn | 19,06 mn | - | |||||
Total Liabilities | 357 mn | 533 mn | 1,14 md | 724 mn | 387 mn | |||||
Common Stock, Total | 36,06 mn | 39,8 mn | 43,63 mn | 51,7 mn | 58,75 mn | |||||
Additional Paid In Capital | 2,65 md | 3,47 md | 4,25 md | - | 6,41 md | |||||
Retained Earnings | −1,44 md | −2,29 md | −3,31 md | - | −4,89 md | |||||
Treasury Stock | - | - | −71,89 mn | - | - | |||||
Comprehensive Income and Other | - | 8,98 mn | 14,16 mn | 764 mn | 22,7 mn | |||||
Total Common Equity | 1,24 md | 1,23 md | 928 mn | 816 mn | 1,59 md | |||||
Total Equity | 1,24 md | 1,23 md | 928 mn | 816 mn | 1,59 md | |||||
Total Liabilities And Equity | 1,6 md | 1,76 md | 2,07 md | 1,54 md | 1,98 md | |||||
Kompletterande objekt | ||||||||||
ECS Total Shares Outstanding on Filing Date | 35,99 mn | 39,55 mn | 43,22 mn | 51,47 mn | 58,38 mn | |||||
ECS Total Common Shares Outstanding | 35,99 mn | 39,74 mn | 43,22 mn | 51,47 mn | 58,38 mn | |||||
Book Value / Share | 34,53 | 30,94 | 21,47 | 15,85 | 27,28 | |||||
Tangible Book Value | 1,24 md | 1,17 md | 874 mn | 816 mn | 1,58 md | |||||
Tangible Book Value Per Share | 34,46 | 29,49 | 20,22 | 15,85 | 27,07 | |||||
Total Debt | 85,76 mn | 130 mn | 787 mn | 524 mn | 119 mn | |||||
Net Debt | −1,29 md | −1,13 md | −641 mn | −654 mn | −1,51 md | |||||
Debt Equivalent Oper. Leases | - | - | - | - | - | |||||
Account Code - Inventory Valuation | 3 | 3 | 5 | 5 | 5 | |||||
Inventories - Raw Materials, Total | - | 14,4 mn | 35,82 mn | 1,29 mn | 7,94 mn | |||||
Inventories - Work In Process, Total | - | 13,72 mn | 29,59 mn | - | - | |||||
Inventories - Finished Goods, Total | - | 36,92 mn | 53,03 mn | - | - | |||||
Buildings, Total | - | 34,1 mn | 36,6 mn | - | - | |||||
Machinery, Total | 69,65 mn | 101 mn | 107 mn | 82,82 mn | 78,57 mn | |||||
Full Time Employees | 179 | 329 | 355 | 196 | 253 |